New orphan medicinal product designation for Friedreich's Ataxia

10 October 2011, EMA/COMP/811210/2011, Human Medicines Development and Evaluation,
Monthly report, The Committee for Orphan Medicinal Products held its 127th plenary meeting on 5-7 October 2011.

Interferon gamma for treatment of Friedreich’s ataxia, Prof. Roberto Testi.